Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
暂无分享,去创建一个
A. Espinasse | P. Flohr | B. Gurel | S. Miranda | S. Carreira | J. Gale | M. Crespo | I. Figueiredo | R. Riisnaes | D. Rodrigues | N. Porta | C. Bertan | P. Rescigno | E. Hall | U. McGovern | Laura Finneran | A. Ferreira | Peter J Hoskin | S. Crabb | Suneil Jain | Duncan McLaren | A. Birtle | Jenny Nobes | Zafar Malik | C. Ralph | Robert Jones | Peter Sankey | Eliot Chadwick | Johann S. de Bono